Adicet Bio, Inc. (ACET) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $776.54M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-105.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $775.04M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-37.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $10.00K; Additional Paid in Capital, Common StockUSD $773.79M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $102.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $8.00K; Additional Paid in Capital, Common StockUSD $693.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $56.00K.
Adicet Bio, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.00K | $776.54M | $-105.00K | $-656.30M | $120.14M | (m) | 3 month · $1.44M | 3 month · $22.00K | (m) | (m) |
| 2026-03-31 | $0.00 | $1.00K | $775.04M | $-37.00K | $-634.94M | $140.06M | (m) | 3 month · $1.30M | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $10.00K | $773.79M | $102.00K | $-614.70M | $159.21M | (m) | 12 month · $14.27M | 12 month · $5.20M | (m) | (m) |
| 2025-09-30 | $0.00 | $8.00K | $693.26M | $56.00K | $-584.18M | $109.14M | (m) | 3 month · $2.53M | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $8.00K | $690.73M | $-41.00K | $-557.33M | $133.37M | (m) | 3 month · $2.91M | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $8.00K | $687.55M | $-9.00K | $-526.11M | $161.45M | (m) | 3 month · $3.18M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $5.00K | $684.48M | $16.00K | $-497.89M | $186.61M | 12 month · $600.00K | 12 month · $22.23M | 12 month · $6.30M | (m) | (m) |
| 2024-09-30 | $0.00 | $8.00K | $680.57M | $121.00K | $-469.17M | $211.53M | (m) | 3 month · $6.78M | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $8.00K | $673.79M | (m) | $-438.69M | $235.11M | (m) | 3 month · $6.00M | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $8.00K | $667.58M | (m) | $-408.79M | $258.80M | 3 month · $600.00K | 3 month · $5.68M | 3 month · $6.30M | (m) | (m) |
| 2023-12-31 | $0.00 | $4.00K | $550.94M | $0.00 | $-380.77M | $170.18M | (m) | 12 month · $20.26M | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $4.00K | $545.96M | (m) | $-351.28M | $194.68M | (m) | 3 month · $5.56M | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $4.00K | $540.46M | $0.00 | $-301.40M | $239.06M | (m) | 3 month · $5.02M | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $4.00K | $535.21M | $0.00 | $-269.00M | $266.21M | (m) | 3 month · $4.76M | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $4.00K | $530.45M | $0.00 | $-238.11M | $292.34M | 12 month · $1.60M | 12 month · $17.13M | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $4.00K | $525.89M | $0.00 | $-208.24M | $317.66M | 3 month · $1.60M | 3 month · $4.19M | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $4.00K | $479.51M | $0.00 | $-186.24M | $293.27M | (m) | 3 month · $4.33M | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $4.00K | $474.79M | $0.00 | $-163.71M | $311.08M | (m) | 3 month · $4.35M | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $4.00K | $471.45M | $0.00 | $-168.32M | $303.13M | 12 month · $823.94M | 12 month · $12.51M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $3.00K | $369.73M | (m) | $-152.51M | $217.22M | (m) | 3 month · $2.53M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $3.00K | $366.84M | (m) | $-138.50M | $228.34M | (m) | 3 month · $2.66M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $3.00K | $363.90M | $2.00K | $-127.64M | $236.26M | (m) | 3 month · $3.04M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $2.00K | $216.13M | $24.00K | $-106.33M | $109.83M | (m) | 12 month · $5.26M | (m) | (m) | (m) |
| 2020-09-30 | (m) | $1.00K | $214.21M | $83.00K | $-97.37M | $116.93M | (m) | 3 month · $2.97M | (m) | (m) | (m) |
| 2020-06-30 | (m) | $4.00K | $237.51M | (m) | $-166.77M | $-72.43M | (m) | 3 month · $351.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | $4.00K | $236.75M | $32.00K | $-161.17M | $-64.53M | (m) | 3 month · $299.00K | (m) | (m) | (m) |
| 2019-12-31 | (m) | $4.00K | $9.26M | $23.00K | $-69.65M | $-60.37M | (m) | 12 month · $1.18M | (m) | (m) | (m) |
| 2019-09-30 | (m) | $4.00K | $234.89M | $109.00K | $-125.24M | $-54.13M | (m) | 3 month · $391.00K | (m) | (m) | (m) |
| 2019-06-30 | (m) | $4.00K | $227.56M | $170.00K | $-100.79M | $-39.74M | (m) | 3 month · $223.00K | (m) | (m) | (m) |
| 2019-03-31 | (m) | $4.00K | $222.88M | $32.00K | $-82.46M | $-37.32M | (m) | 3 month · $251.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | $3.00K | $175.63M | $-41.00K | $-71.39M | $-33.52M | (m) | 12 month · $2.48M | (m) | $175.63M | (m) |
| 2018-09-30 | (m) | $3.00K | (m) | $-76.00K | $-65.64M | $109.34M | (m) | 3 month · $629.00K | (m) | $175.05M | (m) |
| 2018-06-30 | (m) | $3.00K | (m) | $-30.00K | $-57.23M | $117.16M | (m) | 3 month · $402.00K | (m) | $174.42M | (m) |
| 2018-03-31 | (m) | $3.00K | (m) | (m) | $-43.64M | $130.38M | (m) | 3 month · $316.00K | (m) | $174.02M | (m) |
| 2017-12-31 | (m) | $1.00K | (m) | (m) | $-33.78M | $-26.95M | (m) | 12 month · $470.00K | (m) | $1.85M | 12 month · $-1.38M |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2016-07-04 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |